Marco Cattalini

Marco Cattalini

Università degli Studi di Brescia - Brescia / Italy
Medical and Health Sciences / Pediatrics and Child Health
AD Scientific Index ID: 1798947
University of Brescia
person_outline Marco Cattalini's MOST POPULAR ARTICLES
1-) Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy Autoimmunity reviews 19 (7), 102568, 2020
2-) Covid-19 and autoimmunity Autoimmunity reviews 19 (8), 102597, 2020
3-) Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell–stimulating programs in basophils Nature immunology 10 (8), 889-898, 2009
4-) Canakinumab for the treatment of autoinflammatory recurrent fever syndromes New England Journal of Medicine 378 (20), 1908-1919, 2018
5-) Extended report: The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international … Annals of the Rheumatic Diseases 73 (12), 2160, 2014